Excess wei

Excess weight linked to neurological symptoms of long COVID

Excess weight, including overweight and obesity, was linked to neurological symptoms of long COVID, including headaches, vertigo, sleep problems, and depression, according to a meta-analysis of studies comprising almost 140,000 total participants, published in PLOS One. “Although it has been suggested that individuals with increased body mass index are at higher risk of PCC [post-COVID-19 condition], the associations between excess weight and specific PCC-related neurological and neuropsychiatric symptoms remained unclear,” wrote Debora Barbosa Ronca, School of Medical and Health Sciences, ...

Does live zoster jab lower long-term cardiovascular risk?

Live zoster vaccination was associated with a lower risk of overall cardiovascular events, according to a study of over a million participants published in the European Heart Journal. “The association between live zoster vaccination and lower rate...

Metabolic Therapy With GLP-1 RAs Effective for Secondary Prevention in Atrial Fibrillation

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) were more effective than other medical therapies in the setting of secondary prevention in patients with atrial fibrillation (AF) who also have diabetes and are obese, according to a late-breaking...


Sixty Seconds Science


Spotify episodes

Apple podcasts

Google podcasts

Partner

Search:
Date
Filters:
Intranasal
9:18

Intranasal Universal Influenza Vaccine: Promising Data on Blocking Virus Transmission

Presenter: Amy Aspelund
Internal Medicine
WVCDC 2025
Cell-Based
9:27

Cell-Based Therapeutic Vaccination as Adjuvant Therapy for MGMT Unmethylated Glioblastoma

Presenter: William Decker
Internal Medicine
WVCDC 2025
Clinical U
15:23

Clinical Updates for a novel preventative breast cancer vaccine

Presenter: Olivera Finn
Internal Medicine
WVCDC 2025
Which vacc
5:30

Which vaccination programs with pandemic potential have worked and what else can be done to repurpose COVID facilities and incorporate novel platforms?

Presenter: Rajinder Suri
Internal Medicine
WVCDC 2025
Benefits a
9:20

Benefits and challenges of combining vaccines

Presenter: Bill Hausdorff
Internal Medicine
WVCDC 2025
Addressing
6:26

Addressing the burden of long Covid: reaching a global consensus

Presenter: Miranda Baxa
Internal Medicine
WVCDC 2025
Combining
10:04

Combining vaccines is the future of vaccination - report from WVCDC 2025

Presenter: Mark Jit
Internal Medicine
WVCDC 2025
Why lipopr
6:33

Why lipoprotein(a) matters for clinical decisions and patient risk?

Presenter: Martha Gulati
Cardiology
ACC 2025
Chief Medi
9:42

Chief Medical Officer's take on ACC.25

Presenter: Richard J. Kovacs
Cardiology
ACC 2025
Arrhythmia
14:34

Arrhythmia Management: Updates From Recent Practice Guidance Documents

Presenter: John K. Triedman
Cardiology
ACC 2025
Chronic Co
11:29

Chronic Coronary Disease Management in 2025: What's New in the Guidelines?

Presenter: Benjamin H. Freed
Cardiology
ACC 2025
Highlights
16:24

Highlights of ACC.25

Presenter: B. Hadley Wilson
Cardiology
ACC 2025
From Evide
2:49

From Evidence Generation to Implementation: Tackling Unmet Need in ASCVD

Presenter: Ankeet S. Bhatt
Cardiology
ACC 2025
ALIGN-AR r
9:10

ALIGN-AR reports positive outcomes with dedicated TAVI device for aortic regurgitation

Presenter: Raj Makkar
Cardiology
ACC 2025
Shifting t
6:29

Shifting the Paradigm: Lipoprotein(a) in Cardiovascular Disease

Presenter: Alan Brown
Cardiology
ACC 2025
Lorundrost
9:37

Lorundrostat shows continued promise against uncontrolled hypertension

Presenter: Luke Laffin
Cardiology
ACC 2025
Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
The import
11:22

The importance of the anterior interface in eye surgery

Presenter: Marie-José Tassignon
Internal Medicine
Haematolog
17:26

Haematology is at the forefront - interview with EHA President

Presenter: Antonio Almeida
Oncology
Overall Su
13:30

Overall Survival Results of KEYNOTE-564

Presenter: Stefan N. Symeonides
Oncology
General as
1:18

General aspects of the ESH2023 Hypertension Guidelines - What are the major changes?

Presenter: Michel Burnier
Cardiology
How shall
1:23

How shall be treat hypertension and look at cardiac risk factors when we consider proper treatment?

Presenter: Konstantinos Tsioufis
Cardiology
How to tre
1:06

How to treat patients optimally with chronic coronary syndromes in 2023?

Presenter: Luis Henrique Gowdak
Overall Su
20:13

Overall Survival Results of KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma

Presenter: David F. McDermott
Oncology
How novel
1:07

How novel AI model may help physicians distinguish and identify prefibrotic primary myelofibrosis from essential thrombocythemia?

Presenter: Andrew Srisuwananukorn
Hematology
The future
1:10

The future of Multiple Myeloma management

Presenter: Xavier Leleu
Hematology
Benefits o
1:01

Benefits of myeloma regimens in the real world fall well short of trials

Presenter: Alissa Visram
Hematology
The prefer
0:57

The preferred treatment of hypertension with RAAS blockade inhibitors

Presenter: Martin Strauss
Cardiology
What clini
1:16

What clinicians should know about the new ESH guideline regarding hypertension in women?

Presenter: Renata Cifkova
Cardiology
How to man
1:00

How to manage isolated systolic hypertension in the young?

Presenter: Paolo Palatini
Cardiology
Blood pres
1:34

Blood pressure monitoring in general and what we can do to encourage people.

Presenter: Neil Poulter
Cardiology
How to man
1:08

How to manage masked and masked uncontrolled hypertension?

Presenter: Paolo Palatini
Cardiology
ESMO 2023
1:13

ESMO 2023 Scientific Chair's welcome and invitation to next year's ESMO Congress

Presenter: Silke Gillessen
Oncology